ZOLETIL 100 (50 MG/ML + 50 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS
ZOLETIL 100 (50 MG/ML + 50 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS
Authorised
- Tiletamine hydrochloride
- Water for injection
- Zolazepam hydrochloride
Product identification
Medicine name:
ZOLETIL 100 (50 MG/ML + 50 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS
Zoletil 100 50 mg/ml + 50 mg/ml Liofilizat i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
Active substance:
- Tiletamine hydrochloride
- Water for injection
- Zolazepam hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tiletamine hydrochloride290.86milligram(s)1.00Bottle
-
Water for injection5.00millilitre(s)1.00Bottle
-
Zolazepam hydrochloride281.88milligram(s)1.00Bottle
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Dog
- Cat
-
Intravenous use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- 10 vials of 970 mg lyophilisate and 10 vials of 5 ml solvent
- 1 vial of 970 mg lyophilisate and 1 vial of 5 ml solvent
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2613
Reference member state:
-
France
Procedure number:
- FR/V/0283/002
Concerned member states:
-
Austria
-
Finland
-
Germany
-
Ireland
-
Malta
-
Netherlands
-
Poland
-
Romania
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?: